Hoth Net Income Per Share from 2010 to 2026
| HOTH Stock | USD 0.93 0.02 2.11% |
Net Loss | First Reported 2010-12-31 | Previous Quarter (1.16) | Current Value (1.21) | Quarterly Volatility 5.51712852 |
Check Hoth Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hoth Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 668, Depreciation And Amortization of 9.9 M or Interest Expense of 368.8 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.76. Hoth financial statements analysis is a perfect complement when working with Hoth Therapeutics Valuation or Volatility modules.
Hoth | Net Income Per Share | Build AI portfolio with Hoth Stock |
The Net Income Per Share trend for Hoth Therapeutics offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Hoth Therapeutics is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Hoth Therapeutics' Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of Hoth Therapeutics over the last few years. It is Hoth Therapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hoth Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Hoth Net Income Per Share Regression Statistics
| Arithmetic Mean | (6.80) | |
| Coefficient Of Variation | (81.15) | |
| Mean Deviation | 3.98 | |
| Median | (5.24) | |
| Standard Deviation | 5.52 | |
| Sample Variance | 30.44 | |
| Range | 19.8292 | |
| R-Value | 0.03 | |
| Mean Square Error | 32.43 | |
| R-Squared | 0 | |
| Significance | 0.89 | |
| Slope | 0.04 | |
| Total Sum of Squares | 487.02 |
Hoth Net Income Per Share History
About Hoth Therapeutics Financial Statements
Investors use fundamental indicators, such as Hoth Therapeutics' Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Hoth Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Loss | (1.16) | (1.21) |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Hoth Therapeutics Correlation against competitors. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is there potential for Pharmaceuticals market expansion? Will Hoth introduce new products? Factors like these will boost the valuation of Hoth Therapeutics. Market participants price Hoth higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Hoth Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.